Although GLP-1 drugs make headlines for vision risks, other weight-loss medications carry their own eye-related side effects.

Purpose: To investigated the effects of ginsenoside Rb1 on diabetic retinopathy in streptozotocin-induced diabetic rats. Methods: Diabetes was induced by a single intraperitoneal injection of ...

Insights into the genetic basis of retinopathy of prematurity provided by the animal model of oxygen induced retinopathy are examined. Evidence for a genetic component for susceptibility to ...

Ophthalmic Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio 44195, United States Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve ...

Thus, we developed a microfluidic-based liver–skin microphysiological system (LS-MPS) that successfully cocultured hepatic cells (hepaRG cells, human umbilical vein endothelial cells (HUVECs), and LX2 ...

Figure 1. Number of reported cases of drug-induced hearing disorders from Q1 2004 to Q4 2023. Table 3 showed the characteristics of the population with adverse events to hearing impairment, in which ...

Credit: Genentech. Susvimo is indicated for intravitreal use via the Susvimo ocular implant. For patients with diabetic retinopathy, refills of Susvimo are administered every 36 weeks (approximately 9 ...

The purpose of this study was to investigate the potential role and mechanisms by which toll-like receptor 3 (TLR3) influences the progression of the inflammatory response in a rat model of ...

New research has found that hypoglycaemia can worsen diabetic retinopathy by damaging the blood-retina barrier. A study, published in Science Translational Medicine, revealed that diabetic mice in ...

“It turns out I had something called a drug-induced liver injury, which came from my supplements.” The liver is responsible for more than 500 functions in the human body, including filtering ...

Prothena has buried birtamimab for the second time. A phase 3 trial of the anti-amyloid antibody in the rare disease AL amyloidosis missed its primary endpoint, prompting the biotech to end develo ...